Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 101916
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101916
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101916
Figure 3 Dl-3-n-butylphthalide promotes cellular proliferation under high glucose conditions.
A-C: Cell Counting Kit 8 assay was used to assess the effect of Dl-3-n-butylphthalide on cell proliferation; D: Edu assay showed the cell proliferation of human umbilical vein endothelial cells; E: Edu assay showed the cell proliferation of human keratinocytes cells; F: Edu assay showed the cell proliferation of human dermal fibroblasts; G: Quantification of Edu corporation assay in human umbilical vein endothelial cells, human keratinocytes cells, and human dermal fibroblasts. Data expressed as individual values with mean ± SE. dP < 0.0001, cP < 0.001, bP < 0.01, aP < 0.05, nsP > 0.05. HUVEC: Human umbilical vein endothelial cells; HaCaT: Human keratinocyte cells; HDF: Human dermal fibroblasts; HG: High glucose; NBP: Dl-3-n-butylphthalide.
- Citation: Wei WH, Bai YL, Zhu D, Zhang JY, Yin QC, Li Q, Shen CQ, Jin PS. Dl-3-n-butylphthalide ameliorates diabetic foot ulcer by inhibiting apoptosis and promoting angiogenesis. World J Diabetes 2025; 16(4): 101916
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/101916.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.101916